A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Stage IV Disease
Related studies linked through entity extraction aliases.